Two Indian nationals have been charged in the United States over allegedly selling counterfeit Ozempic, a drug used for weight loss. US court charges say Swapnadeep Roy and Vicky Ramancha allegedly imported the fake weight-loss medicine from China and sold it to distributors in the US. Prosecutors allege they could face up to 71 years in prison on separate charges if convicted. The investigation found the counterfeit packaging was designed to look almost identical to the genuine product. Boxes, information leaflets, injection pen label and even the needle were allegedly made to resemble the real Ozempic to prevent buyers from spotting the fraud. US authorities said the FDA seized batches of counterfeit Ozempic in December 2023 and warned people to be cautious about fake versions. Despite that, the charges claim the defendants remained involved in selling counterfeit medicine. Swapnadeep Roy was arrested in Italy, and an Interpol Red Notice was issued for him. The US later sought his extradition from Italy, and he was produced before a court in Tampa, Florida. Roy and Ramancha face six charges, including conspiracy to smuggle, smuggling and offences related to selling counterfeit medicine. The case is pending, with both men charged but not convicted as it moves through the court process.